Chemical industry – Page 100

Feature
Changing the rules of extraction

2013-03-26T00:00:00Z

As the price of oil goes up, reserves previously uneconomical to exploit become attractive. Nuala Moran explores the chemical technology being used
Business
AstraZeneca partners with Moderna for $240 million

2013-03-21T00:00:00Z

Pharma company sheds more jobs and backs messenger RNA therapeutics
Business
Court convicts ex-Aptuit researcher over drug data

2013-03-21T00:00:00Z

Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
Business
Global AstraZeneca restructuring will cost 1600 jobs

2013-03-19T00:00:00Z

Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US
Business
Interpol teams up with pharma

2013-03-18T00:00:00Z

Pharmaceutical crime programme will seek to reduce trade in fake drugs
Business
Dow makes $1.5bn divestiture plans

2013-03-15T00:00:00Z

Liveris in favour of ‘selectively pruning’ further non-core units
Business
Dispute over Arkema finances

2013-03-13T00:00:00Z

French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
Opinion
New antibiotics: what's the hold up?

2013-03-06T00:00:00Z

It’s more a research problem, than a commercial one, says Derek Lowe
Business
University to acquire Shell UK R&D site

2013-03-05T00:00:00Z

Site at Thornton will become a science park under the stewardship of the University of Chester
Business
Alcohol dependence pill approved in EU

2013-03-05T00:00:00Z

Selincro tablets from Lundbeck designed to reduce consumption of alcohol
Business
UK considers patent rule change for trials

2013-03-04T00:00:00Z

Government to change law that organisations say makes the country less appealing as a location for clinical trials
Business
Dow rapped for $1bn tax scheme

2013-03-01T00:00:00Z

Judge opines: ‘tax law deals in economic realities, not legal abstractions’
Business
Does chemical regulation boost innovation?

2013-02-28T00:00:00Z

Report suggests that supply of innovation responds to extra demand created by new laws
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Careers
Toxicologist with pesticides on the brain

2013-02-13T00:00:00Z

Vanessa Fitsanakis’ career in toxicology goes all the way back to the farm where she grew up. Helen Carmichael traces her journey from agriculture to academia
Business
Ozone device for food packaging

2013-02-12T00:00:00Z

Device uses plasma to create ozone inside sealed packaging
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug